Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to 0.76.

  • Xeris Biopharma Holdings' Asset Utilization Ratio rose 3155.81% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 3155.81%. This contributed to the annual value of 0.63 for FY2024, which is 2800.62% up from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Asset Utilization Ratio is 0.76, which was up 3155.81% from 0.76 recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Asset Utilization Ratio registered a high of 0.76 during Q2 2025, and its lowest value of 0.2 during Q1 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.48 (2023), whereas its average is 0.47.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Asset Utilization Ratio skyrocketed by 8436.86% in 2023 and then surged by 2342.47% in 2024.
  • Over the past 5 years, Xeris Biopharma Holdings' Asset Utilization Ratio (Quarter) stood at 0.23 in 2021, then skyrocketed by 49.56% to 0.34 in 2022, then soared by 48.03% to 0.5 in 2023, then grew by 25.08% to 0.63 in 2024, then increased by 19.77% to 0.76 in 2025.
  • Its last three reported values are 0.76 in Q3 2025, 0.76 for Q2 2025, and 0.7 during Q1 2025.